3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abdelrazek, HM; Moustafa, YM; Youssef, ME | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Alloxan Diabetes
Article | Year |
---|---|
Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Cardiotonic Agents; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Interleukin-6; Male; Myeloid Differentiation Factor 88; Myocardium; NF-kappa B; Nicotinic Agonists; Proto-Oncogene Proteins c-akt; Pyridines; Rats, Wistar; Signal Transduction; Streptozocin; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4; Troponin T; Tumor Necrosis Factor-alpha | 2021 |